These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11998381)

  • 1. [Intensive care of children with DIC syndrome based on the use of low molecular weight heparins].
    Chuprova AV; Shmakov AN; Solov'ev ON; Anokhina TIu; Loskutova SA; Pinegina IuS
    Anesteziol Reanimatol; 2002; (1):29-31. PubMed ID: 11998381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
    Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
    Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan.
    Oguma Y; Sakuragawa N; Maki M; Hasegawa H; Nakagawa M
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():34-40. PubMed ID: 1962902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
    García Fernández JR; López Berenguel F; Ais C
    An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
    Campos M
    Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
    Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
    Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
    Mischke R; Fehr M; Nolte I
    Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
    Bick RL; Frenkel EP; Walenga J; Fareed J; Hoppensteadt DA
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ; Shi XB; Yang JG; Hu DY
    Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-molecular heparins: their mechanism of action, pharmacology and clinical use].
    Bashkov GV; Kalishevskaia TM; Golubeva MG; Solov'eva ME
    Eksp Klin Farmakol; 1993; 56(4):66-76. PubMed ID: 8220023
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-molecular-weight heparin].
    Seki Y
    Rinsho Byori; 2011 Feb; Suppl 147():159-63. PubMed ID: 21766526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Low-molecular-weight heparins].
    Rocha E; Páramo JA; Sarrá J
    Med Clin (Barc); 1993 Apr; 100(16):620-7. PubMed ID: 8388527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disseminated intravascular coagulation (DIC) syndrome after open heart surgery (author's transl)].
    Hirata K; Tokuyasu T; Nishimura S; Nuki S; Kasahara T; Yoshida K; Kaku N; Oishi K; Koga M
    Kyobu Geka; 1980 Feb; 33(2):103-11. PubMed ID: 7359786
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-molecular-weight heparin in pediatric patients.
    Sutor AH; Chan AK; Massicotte P
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():31-9. PubMed ID: 15085464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A contribution safety on using low molecular weight heparin in patients with renal failure].
    Gea Rodríguez E; Barral Viñals N; Manso Mardones P; Indo Berges O
    Farm Hosp; 2004; 28(2):101-5. PubMed ID: 15101801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.